Is tirzepatide (TZP 5, 10, 15mg) efficacious in reducing HbA1c and body weight (BW) compared to placebo (PBO) and semaglutide 1mg (SEMA) in people with type 2 diabetes (T2D) irrespective of baseline beta-cell function?
No takes yet. Share an insight, caveat, or question.
Maldonado et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: